Do not compare yourself with the havoc of Corona in China
Indian vaccine gave the ability to fight against corona
Antibodies found in vaccinated after kidney transplant
Apart from the people who got vaccinated, the ability to fight was also found in those who had faced Corona.
Kumar Sanjay Lucknow
The Indian corona vaccine has made us strong to face the corona. Head of the Department of Nephrology, Sanjay Gandhi PGI, Prof. Narayan Prasad has proved this in his research. When researched on the effect of vaccine on people who had undergone kidney transplant, it was found that more than 70 percent sero-conversion was found in those who had received the Indian vaccine. Seroconversion is the development of specific antibodies in the blood serum as a result of infection or vaccination, including vaccination. During infection or vaccination, antigens enter the blood, and the immune system begins to produce antibodies in response. This increases the ability to fight disease. In those who were not vaccinated and got corona infection, sero conversion was also found very good. Pro. Narayan says that one should not be afraid of Covid-19, yes precautions must be taken. Should not be compared to the outbreak in China. China has been very protective of Corona for a long time, while India quickly ended protective measures such as lockdown. We have faced the spread of Corona on a large scale.
Pro. Prasad says that more than 60 percent of people in India have been vaccinated. Our Covi Shield and Co Vaccine both have excellent seroconversion. My own study has shown 70% seroconversion in kidney transplant recipients. This means, vaccines will be more effective in the general population. Indians should be compared with the UK population, where Covi Shield was used and the infection was prevalent in the general population as well. We must be careful to mask ourselves without creating panic... don't let the havoc and panic get the better of you.
This is how the research happened
Research was done on 370 people who had undergone kidney transplant. Of these, antibody levels were seen in 78 people who got the vaccine, 120 who got covishield and 172 who got corona infection. 68 percent of those who got vaccinated, 95 percent of those who got Covi Shield and 90.69 percent of those who got corona infected had good antibody levels.
recognition of research
Chief Researcher Prof. Narayan Prasad, Dr. Brijesh Yadav, Prof. The research done by Dharmendra Bhadauria and others on the subject of sero conversion rate after SARS CoV-2 infection and two doses of other vaccine, Covishield vaccine in renal allograft recipient has been accepted by the Fundral of Immunology.
